U.S. military to screen troops for low testosterone

The U.S. military will soon begin screening service members for low testosterone, a move that could reshape how the armed forces evaluate health and deploy troops.

The push comes as testosterone therapy gains wider attention beyond traditional medical contexts. Social media influencers and direct-to-consumer telehealth platforms have fueled demand, often promoting testosterone as a quick fix for energy, muscle growth, and aging. Last year, sales of testosterone treatments topped $2 billion in the U.S., with online clinics offering quick diagnoses and prescriptions. But medical experts warn that the rush to treat has outpaced the science. The military’s new screening program aims to clarify who truly has a medical need rather than chasing performance or appearance.

Doctors agree that testosterone replacement is appropriate only for men with clinically diagnosed low levels and symptoms like fatigue, low libido, or muscle weakness. Yet studies show nearly one in four men prescribed testosterone don’t have low levels at all. The military’s move follows reports of inconsistent standards across branches when evaluating service members for medical discharge based on hormonal issues. Officials say the screening will bring more uniform criteria and reduce unnecessary medical exemptions.

What happens next could influence broader health policy. The Pentagon’s data may help regulators and insurers separate legitimate need from marketing hype. For now, the surge in demand shows how medical treatments can be reshaped by culture and commerce. Without careful guardrails, what starts as a health safeguard can turn into a trend—and the military’s monitoring might be the first step in pushing back.